STEFANY IRIZARRY: Open Payments
NPI 1679174262 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 15 payments from 9 companies in 2025. Trend: 2023 $490 · 2024 $260 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $106 |
| Novo Nordisk Inc | 2 | $60 |
| ABIOMED | 1 | $51 |
| Amgen Inc. | 3 | $43 |
| Boston Scientific Corporation | 1 | $28 |
| Medtronic, Inc. | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
Products named: Korlym, Ozempic, OTEZLA, General - Pain Management, MINIMED 780G, SAPIEN 3 Ultra RESILIA, The Cologuard Plus Collection Kit, LifeVest.
Industry payments across AZ — which companies pay providers there.
